Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test

Raoel Maan; Milan Sonneveld

doi:10.1111/apt.16311

Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test

Raoel Maan, Milan Sonneveld

Gastroenterology & Hepatology

Research output: Contribution to journal › Editorial › Popular

2 Citations (Scopus)

Original language	English
Pages (from-to)	939-940
Number of pages	2
Journal	Alimentary Pharmacology & Therapeutics
Volume	53
Issue number	8
DOIs	https://doi.org/10.1111/apt.16311
Publication status	Published - Apr 2021

Research programs

EMC OR-01

Access to Document

10.1111/apt.16311Licence: Unspecified

Cite this

@article{c39d074182da42a3b1e0f169b158ee67,

title = "Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test",

author = "Raoel Maan and Milan Sonneveld",

year = "2021",

month = apr,

doi = "10.1111/apt.16311",

language = "English",

volume = "53",

pages = "939--940",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test

AU - Maan, Raoel

AU - Sonneveld, Milan

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85102740658&partnerID=8YFLogxK

U2 - 10.1111/apt.16311

DO - 10.1111/apt.16311

M3 - Editorial

C2 - 33745171

SN - 0269-2813

VL - 53

SP - 939

EP - 940

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 8

ER -

Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test

Research programs

Access to Document

Other files and links

Cite this